BARD1 G491R
Gene Variant Detail

Request Content

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Gene BARD1
Variant G491R
Impact List missense
Protein Effect loss of function
Gene Variant Descriptions BARD1 G491R lies within ANK repeat 2 of the Bard1 protein (UniProt.org). G491R results in decreased interaction with the ubiquitinated nucleosomal core particle (PMID: 34102105), Brca1, Palb2, and Rad51c, impaired homology-directed DNA repair activity, altered subcellular localization, decreased DNA repair post-irradiation, decreased H2A ubiquitination, and increased sensitivity to olaparib and cisplatin treatment in cultured cells (PMID: 39387837).
Associated Drug Resistance
Category Variants Paths

BARD1 mutant BARD1 inact mut BARD1 G491R

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Transcript NM_000465.4
gDNA chr2:g.214767579C>T
cDNA c.1471G>A
Protein p.G491R
Source Database RefSeq
Genome Build GRCh38/hg38
Transcript gDNA cDNA Protein Source Database Genome Build
XM_047445350.1 chr2:g.214767579C>T c.1471G>A p.G491R RefSeq GRCh38/hg38
NM_000465.4 chr2:g.214767579C>T c.1471G>A p.G491R RefSeq GRCh38/hg38

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Molecular Profile Indication/Tumor Type Response Type Therapy Name Approval Status Evidence Type Efficacy Evidence References
BARD1 G491R breast cancer sensitive Cisplatin Preclinical - Cell culture Actionable In a preclinical study, a breast cancer cell line expressing BARD1 G491R was sensitive to Platinol (cisplatin) in culture, demonstrating decreased colony formation (PMID: 39387837). 39387837
BARD1 G491R breast cancer sensitive Olaparib Preclinical - Cell culture Actionable In a preclinical study, a breast cancer cell line expressing BARD1 G491R was sensitive to Lynparza (olaparib) in culture, demonstrating decreased colony formation (PMID: 39387837). 39387837
BARD1 G491R breast cancer sensitive Cisplatin + Olaparib Preclinical - Cell culture Actionable In a preclinical study, a breast cancer cell line expressing BARD1 G491R was sensitive to treatment with the combination of Platinol (cisplatin) and Lynparza (olaparib) in culture, demonstrating decreased colony formation (PMID: 39387837). 39387837
BARD1 G491R ovarian cancer sensitive Cisplatin Preclinical - Cell culture Actionable In a preclinical study, an ovarian cancer cell line expressing BARD1 G491R was sensitive to Platinol (cisplatin) in culture, demonstrating decreased colony formation (PMID: 39387837). 39387837
BARD1 G491R ovarian cancer sensitive Olaparib Preclinical - Cell culture Actionable In a preclinical study, an ovarian cancer cell line expressing BARD1 G491R was sensitive to Lynparza (olaparib) in culture, demonstrating decreased colony formation (PMID: 39387837). 39387837
BARD1 G491R ovarian cancer sensitive Cisplatin + Olaparib Preclinical - Cell culture Actionable In a preclinical study, an ovarian cancer cell line expressing BARD1 G491R was sensitive to treatment with the combination of Platinol (cisplatin) and Lynparza (olaparib) in culture, demonstrating decreased colony formation (PMID: 39387837). 39387837